Neurorehabilitation Devices Market-By Product Type (Neurorobotics, Wearable Devices, BCI, Non-Invasive Stimulators), By Application (Stroke, MS, Parkinsons Disease, Spinal Cord Injury), By End-use (Hospitals, Specialty Clinics) & Forecast, 2024-2032

Description

List of Tables

Neurorehabilitation devices market size is projected to expand at over 13.4% from 2024 to 2032. The increasing prevalence of neurological disorders coupled with the growing aging population is fueling the demand for effective rehabilitation solutions. The rapid technological advancements, including robotic-assisted devices and virtual reality-based therapies are leading to enhanced efficacy of neurorehabilitation. For instance, in February 2023, a provider of digital neuro-therapeutics solutions, MindMaze, launched Izar, a first-of-its-kind smart peripheral for patients with impaired hand motor function, approved by the U.S. FDA and CE-marked from the EU.

The rising awareness about the benefits of early intervention and rehabilitation in neurological conditions will drive the adoption of neurorehabilitation devices. Additionally, the presence of supportive government initiatives is favoring the integration of personalized and home-based rehabilitation solutions. The ongoing R&D activities, focusing on innovations in neurorehabilitation devices will further boost the industry growth.

The neurorehabilitation devices market is segregated into product type, application, end-use, and region.

Based on product type, the industry share from the wearable devices segment is projected to witness 13.7% CAGR from 2024 to 2032. The growth can be attributed to the increasing adoption of portable and user-friendly neurorehabilitation solutions. Wearable devices offer continuous monitoring and personalized rehabilitation experiences for enhancing patient engagement. Moreover, the convenience of incorporating rehabilitation into daily activities and the integration of advanced sensor technologies will fuel the product demand.

Neurorehabilitation devices market from the spinal cord injury application segment may strike a 13% CAGR from 2024 to 2032, owing to the rising incidences of spinal cord injuries. Advanced neurorehabilitation devices help in functional recovery, muscle strengthening, and improving mobility, further contributing to enhanced rehabilitation outcomes for individuals with spinal cord injuries.

Regionally, the Asia Pacific neurorehabilitation devices industry is projected to expand at 13.7% CAGR between 2024 and 2032. The growth can be ascribed to the increasing prevalence of neurological disorders, growing aging population, and rising awareness about advanced rehabilitation solutions. Furthermore, the improvements in healthcare infrastructure and the increasing adoption of technologically advanced neurorehabilitation devices will drive the regional market expansion.

Product Code: 7702

Chapter 1 Methodology & Scope

1.1 Market scope & definition
1.2 Base estimates & workings
1.3 Forecast calculations
1.4 Data sources
- 1.4.1 Primary
- 1.4.2 Secondary
  - 1.4.2.1 Paid sources
  - 1.4.2.2 Unpaid sources

Chapter 2 Executive Summary

2.1 Global neurorehabilitation devices market 360 degree synopsis, 2018 - 2032
- 2.1.1 Regional trends
- 2.1.2 Product type trends
- 2.1.3 Application trends
- 2.1.4 End-use trends

Chapter 3 Neurorehabilitation Devices Industry Insights

3.1 Industry ecosystem analysis
3.2 Technology landscape
3.3 Regulatory landscape
3.4 Industry impact forces
- 3.4.1 Growth drivers
  - 3.4.1.1 Increasing prevalence of neurological disorders
  - 3.4.1.2 Technological advancement in neurorehabilitation devices
  - 3.4.1.3 Growing research and development activities regarding neurological disorders
  - 3.4.1.4 Rising awareness regarding neurorehabilitation devices
- 3.4.2 Industry pitfalls & challenges
  - 3.4.2.1 High cost of devices
  - 3.4.2.2 Stringent regulatory scenario
3.5 Growth potential analysis
- 3.5.1 By product type
- 3.5.2 By application
- 3.5.3 By end-use
3.6 Porter's analysis
3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company market share analysis, 2023
4.3 Competitive analysis of major market players, 2023
4.4 Competitive positioning matrix, 2023
4.5 Strategic outlook matrix, 2023

Chapter 5 Neurorehabilitation Devices Market Size and Forecast, By Product Type, 2018-2032 (USD Million)

5.1 Key trends, by product type
5.2 Neurorobotics
5.3 Wearable devices
5.4 Brain-computer interface (BCI)
5.5 Non-invasive stimulators
5.6 Other product types

Chapter 6 Neurorehabilitation Devices Market Size and Forecast, By Application, 2018-2032 (USD Million)

6.1 Key trends, by application
6.2 Stroke
6.3 Multiple sclerosis (MS)
6.4 Parkinson's disease
6.5 Spinal cord injury
6.6 Traumatic brain injury
6.7 Cerebral palsy
6.8 Other applications

Chapter 7 Neurorehabilitation Devices Market Size and Forecast, By End-use, 2018-2032 (USD Million)

7.1 Key trends, by end-use
7.2 Hospitals
7.3 Specialty clinics
7.4 Other end users

Chapter 8 Neurorehabilitation Devices Market Size and Forecast, By Region, 2018-2032 (USD Million)

8.1 Key trends, by region
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 France
- 8.3.4 Italy
- 8.3.5 Spain
- 8.3.6 Rest of Europe
8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 South Korea
- 8.4.6 Rest of Asia Pacific
8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Mexico
- 8.5.3 Argentina
- 8.5.4 Rest of Latin America
8.6 Middle East & Africa
- 8.6.1 Saudi Arabia
- 8.6.2 South Africa
- 8.6.3 UAE
- 8.6.4 Rest of Middle East & Africa

Chapter 9 Company Profiles

9.1 Bioventus LLC
9.2 Ectron Ltd.
9.3 Hocoma (DIH Medical)
9.4 BIOMETRICS LTD.
9.5 Bionik Laboratories Corp.
9.6 BioXtreme Ltd.
9.7 Ekso bionics holdings, Inc.
9.8 Kinestica
9.9 Saebo, Inc.
9.10 Abbott Laboratories
9.11 Emotiv Inc.
9.12 BrainCo, Inc.
9.13 Permobil AB
9.14 Medtronic Plc